<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Entresto</title>
    <link rel="stylesheet" href="assets/css/bootstrap.min.css">
    <link rel="stylesheet" href="assets/css/style.css">


</head>

<body>


    <header id="header">
        <div class="header-top text-14">
            <div class="container text-center d-sm-flex align-items-center align-items-lg-start justify-content-between ">
                <a href="/" class="logo">
                    <img src="assets/images/logo.svg" alt="">
                </a>
                <div class="d-lg-flex mt-3">
                    <p class="text-color-primary mb-1 mb-lg-0">
                        For Canadian Healthcare Professionals
                    </p>
                    <div class="text-color-primary d-sm-flex align-items-start">
                        <a href="important-safety-information.html">
                            Important Safety Information
                        </a>
                        </a>
                        <a href="#">
                            Francais
                        </a>
                    </div>
                </div>
            </div>
        </div>
        <nav class="navbar navbar-expand-lg navbar-light bg-dark">
            <div class="container">
                <button class="navbar-toggler ms-auto" type="button" data-bs-toggle="collapse"
                    data-bs-target="#navbarSupportedContent" aria-controls="navbarSupportedContent"
                    aria-expanded="false" aria-label="Toggle navigation">
                    <span class="navbar-toggler-icon">
                        <svg viewBox="0 0 24 24" fill="#fff">
                            <path d="M3 18h18v-2H3v2zm0-5h18v-2H3v2zm0-7v2h18V6H3z"></path>
                        </svg>
                    </span>
                </button>
                <div class="collapse navbar-collapse" id="navbarSupportedContent">
                    <ul class="navbar-nav">
                        <li class="nav-item">
                            <a class="nav-link" href="entresto-efficacy.html">
                                Efficacy Data
                            </a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" href="entresto-safety-profile.html">
                                Safety Profile
                            </a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link active" href="entresto-dosing.html">
                                Dosing
                            </a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" href="entresto-moa.html">
                                Mechanism of Action
                            </a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" href="hf-guidelines.html">
                                Guidelines
                            </a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" href="entresto-resources.html">
                                Resources
                            </a>
                        </li>
                    </ul>
                </div>
            </div>
        </nav>
        <div class="header-bottom"></div>
    </header>

    <section class="page-content entresto-dosing">
        <div class="container">
            <h2 class="common-title-1">
                Initiating and titrating ENTRESTO<sup>®</sup> to target dose<sup>1</sup>
            </h2>
            <p class="text-18 pt-3">
                ENTRESTO<sup>®</sup> should only be initiated in clinically stable patients whose baseline systolic
                blood pressure, serum potassium and renal function are at acceptable levels.
            </p>
            <div>
                <div class="mb-4 pb-3">
                    <div class="common-block">
                        <h3>
                            Patients with:
                        </h3>
                        <ul>
                            <li>
                                <span>•</span>
                                <p>
                                    Prior ACE inhibitor or ARB at less than guideline-recommended doses
                                </p>
                            </li>
                            <li>
                                <span>•</span>
                                <p>
                                    Risk for hypotension (≥75 years old, low SBP)
                                </p>
                            </li>
                            <li>
                                <span>•</span>
                                <p>
                                    Moderate hepatic impairment (Child-Pugh B)
                                </p>
                            </li>
                        </ul>
                    </div>
                    <div class="d-flex justify-content-between text-bold px-2 py-1 text-18">
                        <span>
                            Starting dose
                        </span>
                        <span>
                            Target dose
                        </span>
                    </div>
                    <img src="assets/images/entresto-dosing/1.png" alt="">
                    <div class="d-flex text-18 mt-2 dosing-time">
                        <span class="ms-auto me-5 pe-3">
                            After 2-4 weeks as tolerated by patient
                        </span>
                        <span>
                            After 2-4 weeks as tolerated by patient
                        </span>
                    </div>
                </div>
                <div>
                    <div class="common-block">
                        <h3>
                            Patients with:
                        </h3>
                        <ul>
                            <li>
                                <span>•</span>
                                <p>Prior ACE inhibitor or ARB at guideline-recommended doses
                                </p>
                            </li>
                        </ul>
                    </div>
                    <div class="d-flex justify-content-between text-bold px-2 py-1 text-18">
                        <span>
                            Starting dose
                        </span>
                        <span>
                            Target dose
                        </span>
                    </div>
                    <img src="assets/images/entresto-dosing/2.png" alt="">
                    <div class="text-end text-18 mt-2 dosing-time">
                        <span>
                            After 2-4 weeks as tolerated by patient
                        </span>
                    </div>
                </div>
            </div>
            <div class="d-flex flex-column flex-md-row justify-content-between py-3 text-14">
                <span>
                    SBP: systolic blood pressure.
                </span>
                <span>
                    Adapted from the ENTRESTO<sup>®</sup> Product Monograph<sup>1</sup>
                </span>
            </div>
            <h3 class="bg-yellow text-center text-bold text-24 py-4 mt-5">
                Stop ACE inhibitor therapy for a 36-hour washout.<sup>1</sup>
            </h3>
            <div class="text-18 mt-5 pt-2">
                <p class="mb-3">
                    ENTRESTO<sup>®</sup> must <strong>not</strong> be started until <strong>36 hours have passed following
                        discontinuation of ACE inhibitor therapy.<sup>1</sup></strong>
                </p>

                <p class="mb-3">
                    If patients experience tolerability issues, e.g., symptomatic hypotension or hyperkalemia,
                    consideration should be given to temporary down-titration or treatment interruption of ENTRESTO<sup>®</sup>.<sup>1</sup>
                </p>

                <p class="mb-3">
                    ENTRESTO<sup>®</sup> should normally be used in conjunction with other medical treatment for HF, including
                    diuretics, beta-blockers, and mineralocorticoid receptor antagonists, as appropriate and as
                    tolerated.<sup>1</sup>
                </p>

                <p class="text-bold text-22">
                    ENTRESTO<sup>®</sup> must not be administered with any drug formulation containing an ACE inhibitor due to the
                    risk of angioedema and should not be co-administered with any other drug formulation containing an
                    ARB.<sup>1</sup>
                </p>


            </div>
            <h3 class="bg-yellow text-center text-bold text-24 py-4 mt-5">
                ENTRESTO<sup>®</sup> should be used in place of an ACE inhibitor or ARB.<sup>1</sup>
            </h3>
            <div class="common-block reference-block mt-5">
                <p>
                    <span>ACE: angiotensin-converting-enzyme;</span>
                    <span>ARB: angiotensin receptor blocker.</span>

                </p>
            </div>
        </div>
    </section>

    <footer>
        <div class="container">
            <div class="links text-center text-lg-start mb-4 mb-lg-0">
                <a href="privacy-policy.html">
                    Privacy Policy
                </a>
                |
                <a href="terms-of-use.html">
                    Terms of Use
                </a>
                | <a href="#">
                    Cookie Settings
                </a>
            </div>
            <div class="d-flex align-items-lg-end flex-column flex-lg-row">
                <a href="#">
                    <img src="assets/images/footer-logo.svg" alt="">
                </a>
                <p class="mt-3 mt-lg-0">
                    Entresto is a registered trademark. <br>
                    © Novartis Pharmaceuticals Canada Inc. 2022
                </p>
                <div class="footer-right mt-2 mt-lg-0">
                    <p class="mb-3 mb-lg-0">
                        187298E - July 2022
                    </p>
                    <img src="assets/images/footer-img-2.svg" alt="">
                    <img src="assets/images/footer-img-3.svg" alt="">
                </div>
            </div>
        </div>
    </footer>

    <script src="assets/js/jquery.js"></script>
    <script src="assets/js/bootstrap.bundle.min.js"></script>
    <script src="assets/js/index.js"></script>
</body>

</html>